계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Noile-Immune Biotech
company
About
Noile-Immune Biotech is a national cancer research center specializing in the development of cancer immunotherapies.
- 11 - 50
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- ¥1B
- Industries
- Biotechnology
- Founded date
- Apr 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University.They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥3.44B
Noile-Immune Biotech has raised a total of
¥3.44B
in funding over 2 rounds. Their latest funding was raised on
Mar 22, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 22, 2021 | Series C | ¥2.38B | 2 |
BiGEN
|
— | Detail |
| May 31, 2018 | Series Unknown | ¥60M | 2 | — | — | Detail |
| Sep 4, 2017 | Corporate Round | ¥1B | 1 |
Takeda
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
BiGEN
|
Yes | Series C |
|
Takeda
|
Yes | Corporate Round |
Healthcare Innovation
|
— | Series C |
SAIKYO
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
